Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranilast for Mucinoses
NCT03490708Phase 1Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Apr 2018
- Primary completion
- Jun 2022
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of tranilast in Mucinosis, sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Volume change of skin lesions by ultrasound at 12 months. Status: unknown.
02
Drugs
tranilast
03
Conditions
Mucinosis
Beyond the preview
Go deeper on NCT03490708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03490708.